Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
about
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience.Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature.[Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE].
P2860
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
@en
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
@nl
type
label
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
@en
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
@nl
prefLabel
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
@en
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
@nl
P2093
P2860
P1433
P1476
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.
@en
P2093
Albrecht Fiesselmann
Holger Fleischmann
Tobias Wiesner
P2860
P2888
P304
P356
10.1007/S00592-016-0862-0
P577
2016-04-19T00:00:00Z